Differential Specificity and Immunogenicity of Adenovirus Type 5 Neutralizing Antibodies Elicited by Natural Infection or Immunization
Cheng Cheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Gary J. Nabel(National Institutes of Health), C. Richter King(GenVec), Gavin Churchyard(University of the Witwatersrand), Cecilia Morgan(Fred Hutch Cancer Center), Martha Nason(National Institutes of Health), Ann Duerr(Cancer Research Center), Jason G. Gall(GenVec), M. Juliana McElrath(Fred Hutch Cancer Center), Mario Roederer(National Institute of Allergy and Infectious Diseases), Lindsey R. Baden(Brigham and Women's Hospital), Richard A. Koup(Aaron Diamond AIDS Research Center), Michael C. Keefer(University of Rochester Medical Center), Barney S. Graham(National Institutes of Health)
Cited by 75
Related Papers
Integrated analysis of multimodal single-cell data
|Cell|2021|16.2k
T-cell quality in memory and protection: implications for vaccine design
|Nature reviews. Immunology|2008|1.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k